Recent Updates
Recently added Catalysts
OCGN Negative Sentiment Score: 20/100

OCUGEN DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Ocugen, Inc. and Encourages Investors to Contact the Firm

Key Takeaway: A class action lawsuit has been filed against Ocugen, Inc. related to claims of materially false and misleading information. The lawsuit pertains to securities purchased between May 2020 and April 2024, with allegations that Ocugen's financial statements were inaccurate and that the company lacked adequate internal controls. Investors have until June 10, 2024, to apply as lead plaintiffs in the action. The firm handling the case, Bragar Eagel & Squire, encourages affected investors to reach out for more information.

Market Sentiment Analysis

CONCERNS & RISKS

  • A class action lawsuit has been filed against Ocugen, raising concerns about potential legal liabilities.
  • The complaint alleges that Ocugen's financial statements were materially misstated, indicating issues with the company's transparency.
  • The company's internal controls were deemed inadequate, further questioning its operational integrity.
  • Statements made by Ocugen regarding its business prospects are challenged as being materially false or misleading.

Full Press Release Details

NEW YORK, June 07, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN) in the United States District Court for the Eastern District of Pennsylvania on behalf of all persons and entities who purchased or otherwise acquired Ocugen securities between May 8, 2020 and April 1, 2024, both dates inclusive (the “Class Period”). Investors have until June 10, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Click here to participate in the action.
According to the filed complaint, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) Ocugen’s financial statements from May 8, 2020 to the present were materially misstated; (2) Ocugen did not have adequate internal controls; and (3) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times.
If you purchased or otherwise acquired Ocugen shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact Information:
Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Marion Passmore, Esq.

Tags

Frequently Asked Questions

What is the Ocugen class action lawsuit about?

It addresses false statements and misleading information by Ocugen regarding its financial statements and operations.

Who can participate in the Ocugen lawsuit?

All persons or entities that acquired Ocugen securities between May 8, 2020, and April 1, 2024.

What is the deadline to join the Ocugen lawsuit?

Investors have until June 10, 2024, to apply as lead plaintiff.

How can investors contact the law firm for more information?

Investors can email investigations@bespc.com or call (212) 355-4648.

Who is representing investors in this lawsuit?

Bragar Eagel & Squire, P.C. is representing the investors involved.

Last updated: Jun 8, 2024